Detalles de la búsqueda
1.
Case report: Emerging BRCA mutation confers benefit from olaparib after chemotherapy intolerance in advanced triple-negative breast cancer.
Clin Case Rep
; 12(4): e8680, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38571902
2.
Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy.
Front Pharmacol
; 13: 883600, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35991878
3.
[Construction of eukaryotic expression plasmids containing green fluorescent protein gene and CYP19 WT or its variants].
Zhejiang Da Xue Xue Bao Yi Xue Ban
; 40(2): 189-94, 2011 03.
Artículo
en Zh
| MEDLINE | ID: mdl-21488216
4.
Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study.
Ann Transl Med
; 9(16): 1334, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34532471
5.
Efficacy of fulvestrant 500âmg in Chinese postmenopausal women with advanced/recurrent breast cancer and factors associated with prolonged time-to-treatment failure: A retrospective case series.
Medicine (Baltimore)
; 99(29): e20821, 2020 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32702824
6.
Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS.
Anat Rec (Hoboken)
; 294(6): 941-4, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21548109
Resultados
1 -
6
de 6
1
Próxima >
>>